PharmaCyte Biotech Inc (PMCB) financials · $8.6M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
PharmaCyte Biotech Inc (PMCB) $8.6M cap.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$6.85M | -$4.38M |
| Net Income | -$19.4M | $30.7M |
| EPS (Diluted) | -$2.77 | $3.19 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $46.8M | $55.2M |
| Current Assets | $37.4M | $22.4M |
| Cash & Equivalents | $18.6M | $15.2M |
| Total Liabilities | $11.8M | $3.28M |
| Current Liabilities | $826.4K | $2.91M |
| Shareholders' Equity | $33.3M | $51.9M |
| Retained Earnings | -$104.4M | -$85.0M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$5.15M | -$2.98M |
| Investing Cash Flow | $2.00M | -$7.00M |
| Financing Cash Flow | $6.58M | -$25.0M |
| Net Change in Cash | $3.43M | -$35.0M |
FAQ
What is PMCB P/E and revenue?
PharmaCyte Biotech Inc (PMCB) $8.6M cap.
What is PMCB revenue?
PMCB income-statement cache has no revenue figure yet.
Is PMCB profitable?
PharmaCyte Biotech Inc last cached net income is -$19.4M (FY2026).
What are PMCB total assets?
PharmaCyte Biotech Inc last cached total assets are $46.8M (FY2026).
What is PMCB free cash flow?
No cached cash-flow row for PMCB yet.
Not investment advice. Cached statements, not a live tape.